Antibody Therapeutics Market to Reach $597.1 Billion by 2035
The global antibody therapeutics market is projected to grow from USD 311.2 billion in 2026 to USD 597.1 billion by 2035, at a CAGR of 7.5% during the forecast period. The market is experiencing strong growth due to the increasing adoption of antibody-based therapies across oncology, autoimmune diseases, inflammatory disorders, and other chronic conditions.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=178852478
Advancements...
CAR T-Cell Therapy Market Set to Reach USD 13.56 Billion by 2031: Innovation Reshaping Cancer Treatment
Cancer remains one of the world’s leading health challenges, driving continuous innovation in oncology treatments. Among the most transformative breakthroughs in recent years is Chimeric Antigen Receptor (CAR) T-cell therapy, an advanced form of immunotherapy that harnesses the body’s own immune system to fight cancer. Unlike conventional treatments, CAR T-cell therapy genetically engineers...
Genomics Market to Reach $85.09 Billion by 2030
The global genomics market is projected to grow from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, at a CAGR of 12.6% during the forecast period. Market growth is being driven by increasing investments in genomics research, expansion of population genomics initiatives, and a growing focus on rare and genetic diseases.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=613
Advancements...
AI in Genomics Market to Reach $2.0 Billion by 2028
The global artificial intelligence (AI) in genomics market is projected to grow from USD 0.5 billion in 2023 to USD 2.0 billion by 2028, at a CAGR of 32.3% during the forecast period. The rapid growth of this market is driven by the increasing need to accelerate drug discovery timelines, reduce development costs, and extract meaningful insights from vast genomic datasets.
Download PDF...
Biomarkers Market Growth 2031: Precision Medicine, Drug Discovery & Omics Technologies Driving $112.10 Billion Opportunity
The global biomarkers market is projected to grow from USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5% during the forecast period. The market was valued at USD 62.67 billion in 2025. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment...
Ophthalmology Drugs Market to Reach $26.28 Billion by 2030 Driven by Innovation in Retinal and Ocular Therapies
The global Ophthalmology Drugs Market , valued at US$18.34 billion in 2024 stood at US$19.52 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$26.28 billion by the end of the period. This growth is driven by several key factors, including an increasing population affected...
Stem Cell Therapy Market Set to Reach USD 3.65 Billion by 2035: Regenerative Medicine Enters a New Era
Stem cell therapy is rapidly transforming the future of healthcare by offering innovative regenerative solutions for conditions that were once considered difficult or impossible to treat. From musculoskeletal disorders and neurological diseases to cardiovascular conditions and immune-related disorders, stem cell-based therapies are opening new possibilities in personalized and regenerative medicine.
According...
Suppositories Market to Reach $2.05 Billion by 2030
The global suppositories market is projected to grow from USD 1.63 billion in 2025 to USD 2.05 billion by 2030, at a CAGR of 4.7% during the forecast period. Market growth is primarily driven by the rising prevalence of chronic diseases, increasing demand for cost-effective treatment options, and the expanding global geriatric population.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64269069
As...
Tangential Flow Filtration Market: Powering the Next Generation of Biopharmaceutical Manufacturing
The global biopharmaceutical industry is undergoing a remarkable transformation, driven by the growing demand for biologics, biosimilars, vaccines, gene therapies, and personalized medicines. As manufacturers strive to improve production efficiency while maintaining stringent quality standards, advanced downstream processing technologies have become increasingly important. Among these, Tangential...
Biopsy Devices Market: Driving the Future of Early Cancer Diagnosis and Minimally Invasive Healthcare
The global biopsy devices market is witnessing remarkable growth as healthcare providers increasingly prioritize early disease detection, minimally invasive procedures, and precision diagnostics. According to industry estimates, the market was valued at US$6.86 billion in 2023, reached US$7.27 billion in 2024, and is projected to grow at a CAGR of 7.2%, reaching US$11.01 billion by 2030.
The growing...